Latest news
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMTGoldman Sachs's Hader on why AstraZeneca's stock fell on news of possible merger with Bristol Myers - CNBCCNBC · Mon, 03 Aug 2026 21:02:00 GMTAstraZeneca–Bristol Myers Squibb merger 'is not highly likely to happen,' says UBS' Michael Yee - CNBCCNBC · Mon, 03 Aug 2026 17:12:00 GMTAstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed' - CNBCCNBC · Mon, 03 Aug 2026 07:17:39 GMTAstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports - CNBCCNBC · Sun, 02 Aug 2026 20:00:18 GMT